Dizdar, Omer <br/><br/>
Advances in PARP inhibitors for the treatment of breast cancer.  [electronic resource] 

 -  Expert opinion on pharmacotherapy  2015 
 - 2751-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7666 
<br/><br/><label>Standard No.: </label>10.1517/14656566.2015.1100168  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>BRCA1 Protein--genetics<br/>BRCA2 Protein--genetics<br/>Breast Neoplasms--drug therapy<br/>Clinical Trials as Topic<br/>DNA Repair<br/>Drug Resistance, Neoplasm<br/>Female<br/>Humans<br/>Mutation<br/>Ovarian Neoplasms--drug therapy<br/>Phthalazines--therapeutic use<br/>Piperazines--therapeutic use<br/>Poly(ADP-ribose) Polymerase Inhibitors--therapeutic use<br/>Poly(ADP-ribose) Polymerases--metabolism